Short Communication Development of a DNA-based Vaccine Strategy Against Bovine Papillomavirus Infection, Involving the E5 or L2 Gene

Genetics and Molecular Research - Brazil
doi 10.4238/2014.february.20.13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Genetics and Molecular Research

Related search

A DNA Vaccine Formulated With Chemical Adjuvant Provides Partial Protection Against Bovine Herpes Virus Infection in Cattle

Frontiers in Immunology
AllergyImmunology
2017English

Bovine Papillomavirus on the Scene of Crime: Is E5 Oncogene the Only Guilty Party?

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2013English

Protection Against Heterologous Human Papillomavirus Challenge by a Synthetic Lipopeptide Vaccine Containing a Broadly Cross-Neutralizing Epitope of L2

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Golgi Alkalinization by the Papillomavirus E5 Oncoprotein

Journal of Cell Biology
MedicineCell Biology
2000English

Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A Promising Vaccine Strategy Against Flavivirus in Ducks

Scientific Reports
Multidisciplinary
2018English

Tuberculosis Vaccine Development :The Development of a Novel (Preclinical) DNA Vaccine

Human Vaccines
2010English

Papillomavirus E5: The Smallest Oncoprotein With Many Functions

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2011English

Acquired Immunity Against Trypanosoma Cruzi Infection and Vaccine Development

2012English

DNA-Vaccine Platform Development Against H1N1 Subtype of Swine Influenza a Viruses

Viral Immunology
Molecular MedicineImmunologyVirology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy